Form 8-K - Current report:
SEC Accession No. 0001558370-23-015770
Filing Date
2023-09-15
Accepted
2023-09-15 06:15:20
Documents
13
Period of Report
2023-09-15
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20230915x8k.htm   iXBRL 8-K 45975
2 EX-99.1 tmb-20230915xex99d1.htm EX-99.1 22691
  Complete submission text file 0001558370-23-015770.txt   193227

Data Files

Seq Description Document Type Size
3 EX-101.SCH tmb-20230915.xsd EX-101.SCH 3124
4 EX-101.LAB tmb-20230915_lab.xml EX-101.LAB 15266
5 EX-101.PRE tmb-20230915_pre.xml EX-101.PRE 9657
7 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230915x8k_htm.xml XML 4675
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 231256642
SIC: 2834 Pharmaceutical Preparations